Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy
Mohammad Afsar Khan, Deepti Singh, Mohd Jameel, S. Maurya, Swati Singh, Kafil Akhtar, Hifzur R. Siddique
Topics & Concepts
EnzalutamideLupeolProstate cancerAndrogen receptorLNCaPPharmacologyCancer researchAntiandrogenViability assayDU145MedicineChemistryCancerInternal medicineCellBiochemistryProstate Cancer Treatment and ResearchEstrogen and related hormone effectsCancer, Lipids, and Metabolism